Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

First interim dividend

17 Jan 2025 17:14

RNS Number : 8458T
Experian plc
17 January 2025
Β 

Experian plc

Β 

Β 

First interim dividend - exchange rate and Irish dividend withholding tax

Β 

Β 

17 January 2025 - Experian plc, the global information services company, hereby notifies the market that, further to the announcement on 13 November 2024 of a first interim dividend of 19.25 US cents per ordinary share payable on 7 February 2025 to shareholders on the register of members at the close of business on 10 January 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 10 January 2025 to receive payment in US dollars, will be Β£1 = $1.21984 Accordingly, the sterling amount of dividend payable on 7 February 2025 to such shareholders will be approximately 15.7807 pence per share.

Β 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 10 January 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

Β 

Contact:

Β 

Experian

Charles Brown

Company Secretary

+353 (0) 86 819 4473

Β 

Β 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVFLFLDLFIDLIE
Date   Source Headline
27th Mar 20185:29 pmRNSTransaction in Own Shares
26th Mar 20185:22 pmRNSTransaction in Own Shares
26th Mar 201812:34 pmRNSDirector/PDMR Shareholding
23rd Mar 20185:09 pmRNSTransaction in Own Shares
16th Mar 20182:48 pmRNSBlock listing Interim Review
15th Mar 20189:30 amRNSExperian agrees to acquire ClearScore
2nd Mar 20185:37 pmRNSTransaction in Own Shares
28th Feb 201812:49 pmRNSTotal Voting Rights
9th Feb 20185:04 pmRNSTransaction in Own Shares
8th Feb 20185:43 pmRNSTransaction in Own Shares
7th Feb 20185:12 pmRNSTransaction in Own Shares
6th Feb 20185:35 pmRNSTransaction in Own Shares
5th Feb 20185:30 pmRNSTransaction in Own Shares
31st Jan 20181:00 pmRNSTotal Voting Rights
31st Jan 20189:01 amRNSAdditional Listing
18th Jan 20187:39 amRNS3rd Quarter Results
18th Jan 20187:00 amRNSTrading update, third quarter
12th Jan 20185:09 pmRNSFirst interim dividend
12th Jan 20183:50 pmRNSHolding(s) in Company
29th Dec 201711:54 amRNSTotal Voting Rights
21st Dec 201710:00 amRNSDirectorate Change
15th Dec 201710:06 amRNSElections for first interim dividend
12th Dec 20174:59 pmRNSTransaction in Own Shares
11th Dec 20175:43 pmRNSTransaction in Own Shares
8th Dec 20175:25 pmRNSTransaction in Own Shares
7th Dec 20175:35 pmRNSTransaction in Own Shares
6th Dec 20175:36 pmRNSTransaction in Own Shares
5th Dec 20175:49 pmRNSTransaction in Own Shares
4th Dec 20175:47 pmRNSTransaction in Own Shares
1st Dec 20174:57 pmRNSTransaction in Own Shares
30th Nov 20174:22 pmRNSTotal Voting Rights
24th Nov 20174:54 pmRNSTransaction in Own Shares
23rd Nov 20175:42 pmRNSTransaction in Own Shares
22nd Nov 20175:19 pmRNSTransaction in Own Shares
21st Nov 20175:39 pmRNSTransaction in Own Shares
20th Nov 20175:20 pmRNSTransaction in Own Shares
17th Nov 20175:17 pmRNSTransaction in Own Shares
16th Nov 20175:21 pmRNSTransaction in Own Shares
15th Nov 20175:36 pmRNSTransaction in Own Shares
15th Nov 20177:00 amRNSHalf-year Report
31st Oct 20171:28 pmRNSTotal Voting Rights
2nd Oct 20175:55 pmRNSTransaction in Own Shares
29th Sep 20175:40 pmRNSTransaction in Own Shares
29th Sep 201712:57 pmRNSTotal Voting Rights
28th Sep 20175:18 pmRNSTransaction in Own Shares
27th Sep 20175:37 pmRNSTransaction in Own Shares
26th Sep 20175:45 pmRNSTransaction in Own Shares
25th Sep 20175:26 pmRNSTransaction in Own Shares
22nd Sep 20175:42 pmRNSTransaction in Own Shares
21st Sep 20175:38 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.